Cargando…
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging
OBJECTIVES: The current method for testing new drugs against tuberculosis in vivo is the enumeration of bacteria in organs by cfu assay. Owing to the slow growth rate of Mycobacterium tuberculosis (Mtb), these assays can take months to complete. Our aim was to develop a more efficient, fluorescence-...
Autores principales: | Zelmer, Andrea, Carroll, Paul, Andreu, Nuria, Hagens, Kristine, Mahlo, Jacqueline, Redinger, Natalja, Robertson, Brian D., Wiles, Siouxsie, Ward, Theresa H., Parish, Tanya, Ripoll, Jorge, Bancroft, Gregory J., Schaible, Ulrich E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394442/ https://www.ncbi.nlm.nih.gov/pubmed/22635525 http://dx.doi.org/10.1093/jac/dks161 |
Ejemplares similares
-
Optimisation of Bioluminescent Reporters for Use with Mycobacteria
por: Andreu, Nuria, et al.
Publicado: (2010) -
Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase
por: Andreu, Nuria, et al.
Publicado: (2013) -
Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red Reporters
por: Carroll, Paul, et al.
Publicado: (2010) -
Noninvasive biophotonic imaging for studies of infectious disease
por: Andreu, Nuria, et al.
Publicado: (2011) -
Natural Transmission of Plasmodium berghei Exacerbates Chronic Tuberculosis in an Experimental Co-Infection Model
por: Mueller, Ann-Kristin, et al.
Publicado: (2012)